| Tenofovir to prevent hepatitis B transmission in mothers with high viral load CQ Pan, Z Duan, E Dai, S Zhang, G Han, Y Wang, H Zhang, H Zou, B Zhu, ... New England Journal of Medicine 374 (24), 2324-2334, 2016 | 627 | 2016 |
| Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind … M Buti, E Gane, WK Seto, HLY Chan, WL Chuang, T Stepanova, AJ Hui, ... The lancet Gastroenterology & hepatology 1 (3), 196-206, 2016 | 480 | 2016 |
| Virologic factors associated with failure to passive–active immunoprophylaxis in infants born to HBsAg‐positive mothers H Zou, Y Chen, Z Duan, H Zhang, C Pan Journal of viral hepatitis 19 (2), e18-e25, 2012 | 463 | 2012 |
| Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non … HLY Chan, S Fung, WK Seto, WL Chuang, CY Chen, HJ Kim, AJ Hui, ... The lancet Gastroenterology & hepatology 1 (3), 185-195, 2016 | 452 | 2016 |
| Advancing the global public health agenda for NAFLD: a consensus statement JV Lazarus, HE Mark, QM Anstee, JP Arab, RL Batterham, L Castera, ... Nature Reviews Gastroenterology & Hepatology 19 (1), 60-78, 2022 | 428 | 2022 |
| 96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection K Agarwal, M Brunetto, WK Seto, YS Lim, S Fung, P Marcellin, SH Ahn, ... Journal of hepatology 68 (4), 672-681, 2018 | 373 | 2018 |
| An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus CQ Pan, ZP Duan, KR Bhamidimarri, HB Zou, XF Liang, JIE Li, MJ Tong Clinical gastroenterology and hepatology 10 (5), 452-459, 2012 | 339 | 2012 |
| Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ... The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022 | 303 | 2022 |
| Natural history and clinical consequences of hepatitis B virus infection CQ Pan, JX Zhang International journal of medical sciences 2 (1), 36, 2005 | 303 | 2005 |
| Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real‐life practice H Zhang, CQ Pan, Q Pang, R Tian, M Yan, X Liu Hepatology 60 (2), 468-476, 2014 | 269 | 2014 |
| Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B CQ Pan, GR Han, HX Jiang, W Zhao, MK Cao, CM Wang, X Yue, ... Clinical gastroenterology and hepatology 10 (5), 520-526, 2012 | 245 | 2012 |
| Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B AS Lok, CQ Pan, SHB Han, HN Trinh, WJ Fessel, T Rodell, B Massetto, ... Journal of hepatology 65 (3), 509-516, 2016 | 184 | 2016 |
| Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viremic pregnant women: a case series CQ Pan, LJ Mi, C Bunchorntavakul, J Karsdon, WM Huang, G Singhvi, ... Digestive diseases and sciences 57, 2423-2429, 2012 | 166 | 2012 |
| Cesarean section reduces perinatal transmission of hepatitis B virus infection from hepatitis B surface antigen–positive women to their infants CQ Pan, HB Zou, Y Chen, X Zhang, H Zhang, J Li, Z Duan Clinical Gastroenterology and Hepatology 11 (10), 1349-1355, 2013 | 151 | 2013 |
| Risk of vertical transmission of hepatitis B after amniocentesis in HBs antigen-positive mothers W Yi, CQ Pan, J Hao, Y Hu, M Liu, L Li, D Liang Journal of Hepatology 60 (3), 523-529, 2014 | 121 | 2014 |
| Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B) HLY Chan, SH Ahn, TT Chang, CY Peng, D Wong, CS Coffin, SG Lim, ... Journal of hepatology 64 (5), 1011-1019, 2016 | 118 | 2016 |
| The management of chronic hepatitis B in Asian Americans MJ Tong, CQ Pan, HW Hann, KV Kowdley, SHB Han, AD Min, TS Leduc Digestive diseases and sciences 56 (11), 3143-3162, 2011 | 101 | 2011 |
| Barriers to screening for hepatitis B virus infection in Asian Americans KQ Hu, CQ Pan, D Goodwin Digestive diseases and sciences 56 (11), 3163-3171, 2011 | 89 | 2011 |
| Antiviral therapy for chronic hepatitis B in pregnancy CQ Pan, HM Lee Seminars in liver disease 33 (02), 138-146, 2013 | 88 | 2013 |
| Entecavir safety and effectiveness in a national cohort of treatment‐naïve chronic hepatitis B patients in the US–the ENUMERATE study J Ahn, HM Lee, JK Lim, CQ Pan, MH Nguyen, W Ray Kim, A Mannalithara, ... Alimentary pharmacology & therapeutics 43 (1), 134-144, 2016 | 86 | 2016 |
